You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 30, 2024

MICAFUNGIN IN SODIUM CHLORIDE 0.9% Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Micafungin In Sodium Chloride 0.9%, and when can generic versions of Micafungin In Sodium Chloride 0.9% launch?

Micafungin In Sodium Chloride 0.9% is a drug marketed by Baxter Hlthcare Corp and is included in one NDA.

The generic ingredient in MICAFUNGIN IN SODIUM CHLORIDE 0.9% is micafungin sodium. There are eight drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the micafungin sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Micafungin In Sodium Chloride 0.9%

A generic version of MICAFUNGIN IN SODIUM CHLORIDE 0.9% was approved as micafungin sodium by FRESENIUS KABI USA on May 17th, 2019.

  Try a Trial

Summary for MICAFUNGIN IN SODIUM CHLORIDE 0.9%
Drug patent expirations by year for MICAFUNGIN IN SODIUM CHLORIDE 0.9%
Recent Clinical Trials for MICAFUNGIN IN SODIUM CHLORIDE 0.9%

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Wake Forest University Health SciencesPhase 4
Scynexis, Inc.Phase 3
Yung Shin Pharm. Ind. Co., Ltd.Phase 4

See all MICAFUNGIN IN SODIUM CHLORIDE 0.9% clinical trials

Pharmacology for MICAFUNGIN IN SODIUM CHLORIDE 0.9%
Anatomical Therapeutic Chemical (ATC) Classes for MICAFUNGIN IN SODIUM CHLORIDE 0.9%

US Patents and Regulatory Information for MICAFUNGIN IN SODIUM CHLORIDE 0.9%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare Corp MICAFUNGIN IN SODIUM CHLORIDE 0.9% micafungin sodium SOLUTION;INTRAVENOUS 216142-001 Sep 29, 2023 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Baxter Hlthcare Corp MICAFUNGIN IN SODIUM CHLORIDE 0.9% micafungin sodium SOLUTION;INTRAVENOUS 216142-002 Sep 29, 2023 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Baxter Hlthcare Corp MICAFUNGIN IN SODIUM CHLORIDE 0.9% micafungin sodium SOLUTION;INTRAVENOUS 216142-003 Sep 29, 2023 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.